Gilmartin Geoffrey S. 4
4 · PROTEOSTASIS THERAPEUTICS, INC. · Filed Feb 5, 2018
Insider Transaction Report
Form 4
Gilmartin Greffrey S.
Chief Development Officer
Transactions
- Award
Restricted Stock Units
2018-02-01+24,100→ 24,100 total→ Common Stock (24,100 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of PTI common stock.
- [F2]The restricted stock units shall vest in full on February 1, 2019.